mhurhangee/ep-ind-claims huggingface dataset:
Open revolute joint for an eccentric screw pump in the field of sanitation with an internal joint head of a joint shaft and an outer joint head of a drive shaft wherein each joint head (10, 12) has at least one diametrical boring (14, 15, 16), through which a bolt provided with a cap (20, 22) at each of both ends penetrates, characterised in that at its front side the inner joint head is provided with at least two channels (26, 28) which are arranged eccentrically with regard to the longitudinal axis of the joint shaft, wherein the channels (26, 28) each extend from the longitudinal axis of the drive shaft in the direction of the outer side of the revolute joint at an angle A of 10° to 30° and up to the diametrical boring.
A method of producing type I collagen in a plant or an isolated plant cell comprising: (a) targeting to a vacuole of the plant or the isolated plant cell: a collagen alpha I chain encoded by SEQ ID NO: 1; a collagen alpha II chain encoded by SEQ ID NO: 4; a human prolyl 4 hydroxylase (P4H) alpha subunit encoded by SEQ ID NO: 14; and a human prolyl 4 hydroxylase (P4H) beta subunit encoded by SEQ ID NO: 12; and (b) harvesting said plant or plant cell and isolating the collagen, thereby producing type I collagen. (a) targeting to a vacuole of the plant or the isolated plant cell: a collagen alpha I chain encoded by SEQ ID NO: 1; a collagen alpha II chain encoded by SEQ ID NO: 4; a human prolyl 4 hydroxylase (P4H) alpha subunit encoded by SEQ ID NO: 14; and a human prolyl 4 hydroxylase (P4H) beta subunit encoded by SEQ ID NO: 12; and a collagen alpha I chain encoded by SEQ ID NO: 1; a collagen alpha II chain encoded by SEQ ID NO: 4; a human prolyl 4 hydroxylase (P4H) alpha subunit encoded by SEQ ID NO: 14; and a human prolyl 4 hydroxylase (P4H) beta subunit encoded by SEQ ID NO: 12; and (b) harvesting said plant or plant cell and isolating the collagen, thereby producing type I collagen.
An air mat cell unit comprising: a middle-level cell that is formed in an elongated bag-like shape using a plastic sheet and has an air supply port through which air is supplied into the middle-level cell; a pair of first and second lower-level cells (26, 27) each formed in an elongated bag-like shape using a plastic sheet, each of the first and second lower-level cells (26, 27) having a length smaller than the length of the middle-level cell, each lower-level cell including an air supply port through which air is supplied into the lower-level cell, the first and second lower-level cells (26, 27) being attached to a lower surface of the middle-level cell in a longitudinal direction of the middle-level cell, the first and second lower-level cells (26, 27) communicating with each other; and a plurality of pairs of upper-level cells (28, 29, 30) each formed in a bag-like shape using a plastic sheet and attached to an upper surface of the middle-level cell in the longitudinal direction of the middle-level cell, wherein the upper-level cells (28, 29, 30) in each pair extend parallel with each other, communicate with each other, and communicate with the middle-level cell, a clearance (G1, G2) is set between a specific pair of the upper-level cells and another pair of the upper-level cells (28, 30) adjacent to the specific pair of the upper-level cells, and the sum of the lengths of the pairs of the upper-level cells (28, 29, 30) is set smaller than the length of the middle-level cell. a middle-level cell that is formed in an elongated bag-like shape using a plastic sheet and has an air supply port through which air is supplied into the middle-level cell; a pair of first and second lower-level cells (26, 27) each formed in an elongated bag-like shape using a plastic sheet, each of the first and second lower-level cells (26, 27) having a length smaller than the length of the middle-level cell, each lower-level cell including an air supply port through which air is supplied into the lower-level cell, the first and second lower-level cells (26, 27) being attached to a lower surface of the middle-level cell in a longitudinal direction of the middle-level cell, the first and second lower-level cells (26, 27) communicating with each other; and a plurality of pairs of upper-level cells (28, 29, 30) each formed in a bag-like shape using a plastic sheet and attached to an upper surface of the middle-level cell in the longitudinal direction of the middle-level cell, wherein the upper-level cells (28, 29, 30) in each pair extend parallel with each other, communicate with each other, and communicate with the middle-level cell, a clearance (G1, G2) is set between a specific pair of the upper-level cells and another pair of the upper-level cells (28, 30) adjacent to the specific pair of the upper-level cells, and the sum of the lengths of the pairs of the upper-level cells (28, 29, 30) is set smaller than the length of the middle-level cell.
A multi-vane throttling valve for a vacuum process chamber having a throttle chamber body with a through-opening, an inside exposed to the vacuum process chamber and an outside exposed to atmospheric pressure, a plurality of rotatable vanes mounted within the through-opening for controlling a flow of gases through the through-opening, and a drive mechanism for rotating the plurality of rotatable vanes, the valve characterized in that each of the plurality of rotatable vanes includes: a reciprocal vane pivotally connected to a back side of each of the plurality of rotatable vanes and extending backwardly away from each of the respective rotatable vane; and a stationary reciprocal vane angling assembly fixed in a predefined position, the vane angling assembly having an assembly pin extending transversely toward the reciprocal vane a predefined distance sufficient to support the reciprocal vane; whereby the stationary angling assembly causes the reciprocal vane to pivot in a range between a substantially parallel position with the respective rotatable vane and a transverse position with the respective rotatable vane when the respective rotatable vane is rotated to control the flow of gases through the through-opening. a reciprocal vane pivotally connected to a back side of each of the plurality of rotatable vanes and extending backwardly away from each of the respective rotatable vane; and a stationary reciprocal vane angling assembly fixed in a predefined position, the vane angling assembly having an assembly pin extending transversely toward the reciprocal vane a predefined distance sufficient to support the reciprocal vane; whereby the stationary angling assembly causes the reciprocal vane to pivot in a range between a substantially parallel position with the respective rotatable vane and a transverse position with the respective rotatable vane when the respective rotatable vane is rotated to control the flow of gases through the through-opening.
A heat-exchanger module with a longitudinal axis comprising at least two fluid circuits, the first of which comprises at least one pair of channels (1, 2) for fluid circulation, each extending parallel to the longitudinal axis, wherein the two channels of the same pair are stacked on top of one another and are in communication with one another in a plurality of crossing areas each defining an area for mixing the fluid with itself in the first circuit, each channel having at least in part a curved zigzag profile, the curved zigzag profile being regular along its length, characterized in that the regular curved zigzag profile includes bends (14, 16; 24, 26) and straight segments, a straight segment (15; 25) connecting two consecutive bends.
A method for triggering resource configuration, characterized by: determining, by a user equipment, UE, in Cell_Paging Channel, Cell_PCH, state, that the UE has data to send or receive. when the UE figures out that a Transport Channel Traffic Volume of the UE is larger than a configured threshold, transmitting, by the UE, a MEASUREMENT REPORT message carrying an indication to a network side, wherein the indication is used to trigger resource configuration for the UE at the network side; and triggering, by the UE, state transition from the Cell_PCH state to Cell_Forward Access Channel, Cell_FACH, state. determining, by a user equipment, UE, in Cell_Paging Channel, Cell_PCH, state, that the UE has data to send or receive. when the UE figures out that a Transport Channel Traffic Volume of the UE is larger than a configured threshold, transmitting, by the UE, a MEASUREMENT REPORT message carrying an indication to a network side, wherein the indication is used to trigger resource configuration for the UE at the network side; and triggering, by the UE, state transition from the Cell_PCH state to Cell_Forward Access Channel, Cell_FACH, state.
A method of forming a polymer coating on a substrate, the method comprising the steps of: providing in an evacuated reaction chamber a substrate having a surface to be coated; providing a first source of polymer forming material and a second source of radicals; the first source and the second source are separated from each other and from the reaction chamber, and in that the polymer forming material and the radicals are at least temporarily conducted contemporaneously but spatially separated to the substrate's surface, so that a reaction of the polymer forming material with the radicals is avoided before they reach the substrate's surface; characterized in that the polymer forming material and the radicals are at least partially sprayed onto the substrate's surface in the form of parallel streams (13, 14), and wherein the streams of polymer forming material and the streams of radicals are sprayed onto the substrate's surface in a spatially alternating manner. providing in an evacuated reaction chamber a substrate having a surface to be coated; providing a first source of polymer forming material and a second source of radicals; the first source and the second source are separated from each other and from the reaction chamber, and in that the polymer forming material and the radicals are at least temporarily conducted contemporaneously but spatially separated to the substrate's surface, so that a reaction of the polymer forming material with the radicals is avoided before they reach the substrate's surface; the polymer forming material and the radicals are at least partially sprayed onto the substrate's surface in the form of parallel streams (13, 14), and wherein the streams of polymer forming material and the streams of radicals are sprayed onto the substrate's surface in a spatially alternating manner.
A tool for use with a pair of elongated medical devices (90, 152) comprising: a barrel defining an elongated bore open between a proximal end and a distal end and sized to receive an elongated medical device at a corresponding one of said proximal and distal ends; a first side opening defined in said barrel and communicating with said elongated bore extending from said proximal end toward said distal end; a second side opening defined in said barrel and communicating with said elongated bore extending from said distal end toward said proximal end, said second side opening angularly offset relative to said first side opening; and an intermediate side opening defined in said barrel and communicating with said elongated bore, said intermediate side opening communicating between said first and second side openings (106, 108), wherein said side openings (106, 108) are sized to permit removal of one of said elongated medical devices from said elongated bore and wherein said barrel includes an insertion portion that is sized and configured for percutaneous insertion into the body of a patient. a barrel defining an elongated bore open between a proximal end and a distal end and sized to receive an elongated medical device at a corresponding one of said proximal and distal ends; a first side opening defined in said barrel and communicating with said elongated bore extending from said proximal end toward said distal end; a second side opening defined in said barrel and communicating with said elongated bore extending from said distal end toward said proximal end, said second side opening angularly offset relative to said first side opening; and an intermediate side opening defined in said barrel and communicating with said elongated bore, said intermediate side opening communicating between said first and second side openings (106, 108), wherein said side openings (106, 108) are sized to permit removal of one of said elongated medical devices from said elongated bore and wherein said barrel includes an insertion portion that is sized and configured for percutaneous insertion into the body of a patient.
A composition for use in the treatment of a herpes viral infection consisting of: a. a therapeutically effective amount of acyclovir; b. 2-deoxy-D-glucose; and c. a pharmaceutically acceptable carrier, wherein the pharmaceutically acceptable carrier optionally further comprises one or more of a sweetener, flavoring agent, colorant, opacifier, penetration enhancer, oil, waxy compound, surfactant, stabilizer, gelling agent, moisturizer, water or preservative. a. a therapeutically effective amount of acyclovir; b. 2-deoxy-D-glucose; and c. a pharmaceutically acceptable carrier, wherein the pharmaceutically acceptable carrier optionally further comprises one or more of a sweetener, flavoring agent, colorant, opacifier, penetration enhancer, oil, waxy compound, surfactant, stabilizer, gelling agent, moisturizer, water or preservative.
A biocide composition comprising at least the following components: a) calcium fluoride b) a salicylic acid ester c) at least one organic acid selected from the group comprising or consisting of cinnamic acid, rosmarinic acid, vanillic acid, ascorbic acid, abscisic acid, mandelic acid, mevalonic acid, aspartic acid, fumaric acid, gallic acid, quinic acid, boswellic acid, carnosic acid, chlorogene acid, caffeic acid, other hydroxycarboxylic acids, or a salt or ester thereof, and salicylic acid or a salt thereof, or thymol or citronellal, d) a cationic polymer which is selected from the group consisting of a poly(alkylene)guanidin, in particular poly(hexamethylen)guanidin (PHMG), e) water. a) calcium fluoride b) a salicylic acid ester c) at least one organic acid selected from the group comprising or consisting of cinnamic acid, rosmarinic acid, vanillic acid, ascorbic acid, abscisic acid, mandelic acid, mevalonic acid, aspartic acid, fumaric acid, gallic acid, quinic acid, boswellic acid, carnosic acid, chlorogene acid, caffeic acid, other hydroxycarboxylic acids, or a salt or ester thereof, and salicylic acid or a salt thereof, or thymol or citronellal, d) a cationic polymer which is selected from the group consisting of a poly(alkylene)guanidin, in particular poly(hexamethylen)guanidin (PHMG), e) water.
A cellular radio communications system comprising a cellular communications network and at least one mobile terminal, said terminal being provided with determining and reporting means for determining the moving speed of the terminal and reporting the determined terminal moving speed to said network for use as a basis for selection of a radio bearer to support a required quality of service, characterised in that a terminal moving speed measure is included in the RRC connection request message sent at the establishment of said call or connection setup.
An automated specimen processing system, comprising: a slide ejector having a first portion for pushing a plurality of slides to break a bond between the plurality of slides and a slide carrier; and a second portion for ejecting one slide from the plurality of slides from the slide carrier, wherein the plurality of slides are horizontally aligned and rest on a corresponding plurality of flat surfaces in the slide carrier to enable alignment and even spacing via gravitational forces.
Controllable scent sample dispenser, comprising: a microdosing device for outputting, during an activation state, a scent sample at a scent sample outlet to the environment, wherein the microdosing device is placeable adjacent to an animal's nose so that a distance between the outlet of the microdosing device and a nare or nostril of the animal's nose is within a predefined range, wherein the microdosing device comprises a micro-membrane or micro-diaphragm pump with a pump chamber providing a stroke volume, and a microdosing driver unit for adjusting a dosing rate of the scent sample output at the scent sample outlet by selectively activating the microdosing device; wherein the microdosing driver unit is configured to adjust the dosing rate of the scent sample output at the scent sample outlet based on the stroke volume "ΔV" of the micropump and a number "n" of pump strokes or diaphragm excursions for transporting the carrier gas in a predetermined direction to the scent sample outlet. a microdosing device for outputting, during an activation state, a scent sample at a scent sample outlet to the environment, wherein the microdosing device is placeable adjacent to an animal's nose so that a distance between the outlet of the microdosing device and a nare or nostril of the animal's nose is within a predefined range, wherein the microdosing device comprises a micro-membrane or micro-diaphragm pump with a pump chamber providing a stroke volume, and a microdosing driver unit for adjusting a dosing rate of the scent sample output at the scent sample outlet by selectively activating the microdosing device; wherein the microdosing driver unit is configured to adjust the dosing rate of the scent sample output at the scent sample outlet based on the stroke volume "ΔV" of the micropump and a number "n" of pump strokes or diaphragm excursions for transporting the carrier gas in a predetermined direction to the scent sample outlet.
A method of scaling amperometric data obtained during an electrochemical analysis of an analyte of interest to compensate for hematocrit and/or temperature, the method comprising the steps of: applying to a body fluid sample a test sequence comprising an AC block of low-amplitude signals and at least one DC block, wherein the body fluid sample comprises the analyte of interest; measuring AC and DC current responses to an electro-active species indicative of the analyte of interest; and scaling the amperometric data to obtain a compensated current that minimizes an influence of Hct and/or temperature on the analysis of the analyte of interest, wherein the scaling is performed in accordance with the following equation: scaled DC = DC / Y OP, wherein scaled DC is the scaled DC current response, DC is the unscaled DC current response, Y is the admittance and OP is the optimized power, wherein the admittance corresponds to a 20 kHz applied potential and the optimized power has been iterated between 0 to 10 through a Pearson correlation calculated between the scaled DC current response and one of the two variables of interest, wherein the variables of interest are hematocrit and temperature; wherein the method further comprises a step of estimating the analyte concentration based upon the scaled amperometric data, wherein the analyte is glucose. applying to a body fluid sample a test sequence comprising an AC block of low-amplitude signals and at least one DC block, wherein the body fluid sample comprises the analyte of interest; measuring AC and DC current responses to an electro-active species indicative of the analyte of interest; and scaling the amperometric data to obtain a compensated current that minimizes an influence of Hct and/or temperature on the analysis of the analyte of interest, wherein the scaling is performed in accordance with the following equation: scaled DC = DC / Y OP, wherein scaled DC is the scaled DC current response, DC is the unscaled DC current response, Y is the admittance and OP is the optimized power, wherein the admittance corresponds to a 20 kHz applied potential and the optimized power has been iterated between 0 to 10 through a Pearson correlation calculated between the scaled DC current response and one of the two variables of interest, wherein the variables of interest are hematocrit and temperature; wherein the method further comprises a step of estimating the analyte concentration based upon the scaled amperometric data, wherein the analyte is glucose. wherein scaled DC is the scaled DC current response, DC is the unscaled DC current response, Y is the admittance and OP is the optimized power, wherein the admittance corresponds to a 20 kHz applied potential and the optimized power has been iterated between 0 to 10 through a Pearson correlation calculated between the scaled DC current response and one of the two variables of interest, wherein the variables of interest are hematocrit and temperature; wherein the method further comprises a step of estimating the analyte concentration based upon the scaled amperometric data, wherein the analyte is glucose.
Method for manufacturing a turbine engine blade from composite material comprising: - a first step of producing a preform having a general longitudinal orientation by weaving a single piece, said weave being a three-dimensional yarn weave, said preform comprising a blade root part and a blade vane part; - a second step of placing the preform in a lower part of a mould, a recess of which substantially matches lower parts of the blade root part and of the blade vane part of the preform, the blade root part being received with a longitudinal clearance relative to the lower part of the mould; - a third step of closing the mould, which step consists in placing an upper part of said mould, a recess of which matches upper parts of the blade root part and of the blade vane part of the preform, on the lower part of the mould containing the preform; - a fourth step of vacuum injecting a resin into the mould with a view to impregnating the preform and to forming a rigid blade following resin polymerisation, characterised in that it comprises: - during the first step, at least one sub-step of inserting a position marker into the preform; - during the second step, at least one sub-step of fitting an insert into the mould forming a reference mark, the position of said insert being clearly defined relative to the lower part of the mould, at least one sub-step of compacting the preform in said mould using said insert, and at least one sub-step of checking the position of the marker relative to said reference mark. - a first step of producing a preform having a general longitudinal orientation by weaving a single piece, said weave being a three-dimensional yarn weave, said preform comprising a blade root part and a blade vane part; - a second step of placing the preform in a lower part of a mould, a recess of which substantially matches lower parts of the blade root part and of the blade vane part of the preform, the blade root part being received with a longitudinal clearance relative to the lower part of the mould; - a third step of closing the mould, which step consists in placing an upper part of said mould, a recess of which matches upper parts of the blade root part and of the blade vane part of the preform, on the lower part of the mould containing the preform; - a fourth step of vacuum injecting a resin into the mould with a view to impregnating the preform and to forming a rigid blade following resin polymerisation, - during the first step, at least one sub-step of inserting a position marker into the preform; - during the second step, at least one sub-step of fitting an insert into the mould forming a reference mark, the position of said insert being clearly defined relative to the lower part of the mould, at least one sub-step of compacting the preform in said mould using said insert, and at least one sub-step of checking the position of the marker relative to said reference mark.